We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Researchers say device developed in London could help thousands suffering from vascular disease
The industry is under pressure from increasing wages after loading up on leveraged loans
Blueprint relies on ‘virtual’ wards and improved community care to alleviate bottlenecks
Shortage of doctors with university posts is putting health service on ‘dangerous precipice’
Short-termism and suspicion in parts of government risk our valuable future in precision medicine
Tight budgets and US reforms are ending a truce between the industry and health authorities
Officials row with Pfizer over price as villages struggle to obtain antiviral medication
We must carefully consider how changes in the funding model might affect the healthcare system
UK and EU must balance health cost control with plans to grow life sciences
What the Britain’s Healthiest Workplace data tell us about the nation’s wellbeing, as tough economic times beckon. Also: counting the cost of rising long-term sickness on the economy; how organisations can tackle rising levels of exhaustion and retain staff; workspace designers are going all out on domesticity
AbbVie and Eli Lilly take action after clawback payments on branded drugs reach a quarter of UK sales
German group’s drugs chief warns EU and UK are dissuading investment as company prioritises US and China
Threat comes ahead of another week of industrial action by nurses, ambulance drivers and rail workers
Faced with long waits for treatment, millions pay for care
Starting with primary care, investment combined with modernisation can deliver better outcomes for patients
Operators say higher tariff would allow them to attract and keep staff as hospitals look to free up space
Structure and funding of the UK health system should be re-examined for a new era
Narrow definition of cases leaves claimants on the hook after state-backed policies drop free care
Inclusive Capital takes €400mn stake as German group grapples with legacy of Monsanto takeover
Call for ‘urgent clarification’ on ministers’ plans for up to £250mn going towards easing pressure on NHS
Agreement is one of several announced as major healthcare conference begins in San Francisco
High price of treatment and restrictions on medicine developed by Eisai and Biogen will limit patient access initially
Other countries have found big answers to managing ageing populations and it’s time Britain did, too
Covid-19 vaccine maker hails ‘huge’ investment aimed at recruiting 10,000 participants with NHS
A successful listing would focus J&J on its pharmaceutical and medical-device business
International Edition
